Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer

Stopped early · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Celecoxib may stop the growth of tumor cells by blocking the enzymes necessary for their growth and by stopping blood flow to the tumor. It is not yet known which regimen of celecoxib is more effective in treating breast cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of two regimens of celecoxib in treating women who have metastatic or recurrent breast cancer

Key facts

Study ID

NCT00045591

Run by

Alliance for Clinical Trials in Oncology

People needed

39

Starts

2003-02-01

Expected to finish

2010-01-01

Last updated by the study team

2017-01-11

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
• Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center — Los Angeles, California, United States
• Naval Medical Center - San Diego — San Diego, California, United States
• Veterans Affairs Medical Center - San Diego — San Diego, California, United States
• UCSF Comprehensive Cancer Center — San Francisco, California, United States
• Veterans Affairs Medical Center - San Francisco — San Francisco, California, United States
• CCOP - Christiana Care Health Services — Newark, Delaware, United States
• Lombardi Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• Veterans Affairs Medical Center - Washington, DC — Washington D.C., District of Columbia, United States
• Broward General Medical Center — Fort Lauderdale, Florida, United States
• Memorial Regional Cancer Center at Memorial Regional Hospital — Hollywood, Florida, United States
• CCOP - Mount Sinai Medical Center — Miami Beach, Florida, United States
• MBCCOP - University of Illinois at Chicago — Chicago, Illinois, United States
• Veterans Affairs Medical Center - Chicago (Westside Hospital) — Chicago, Illinois, United States
• University of Chicago Cancer Research Center — Chicago, Illinois, United States
• Lagrange Oncology Associates — La Grange, Illinois, United States
• CCOP - Illinois Oncology Research Association — Peoria, Illinois, United States
• West Suburban Center for Cancer Care — River Forest, Illinois, United States
• Fort Wayne Medical Oncology and Hematology, Incorporated — Fort Wayne, Indiana, United States
• CCOP - Northern Indiana CR Consortium — South Bend, Indiana, United States
• Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
• Baptist Hospital East - Louisville — Louisville, Kentucky, United States
• Greenebaum Cancer Center at University of Maryland Medical Center — Baltimore, Maryland, United States
• Northeast Alabama Regional Medical Center — Anniston, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.